Work

The importance of oestrogens in males

Year: 2003
Type: review
Abstract: For a long time oestrogens in the human male have been regarded as a mere by-product of testosterone synthesis. Only since the description of an oestrogen-resistant man (Smith et al., 1994) has it been fully realized that oestrogens play an import role in bone homeostasis, cardiovascular health and pituitary–gonadal interactions in men. Due to a disruptive homozygous oestrogen receptor alpha (ERα) mutation, this man was virtually insensitive to oestrogens which lead to osteoporosis, unfused epiphyses resulting in linear growth into adulthood, increased gonadotrophin levels and evidence of premature atherosclerosis (Sudhir et al., 1997a) and endothelial dysfunction (Sudhir et al., 1997b). Additionally, there was low viability of sperm and glucose intolerance with acanthosis nigrans. Two adult aromatase-deficient men showed, besides undetectable oestrogen levels, low bone mass, unfused epiphyses, increased gonadotrophins and a unfavourable lipid profile (Morishima et al., 1995; Carani et al., 1997). Earlier, Korach (1994) described similar observations in ERα knockout mice. Heterozygous mice exhibited no obvious phenotypic abnormalities. Homozygous male mice proved to be infertile, showing smaller testes with dysmorphic seminiferous tubules and a sperm count of less than 10% compared to normal mice. Finally, bone mineral density was 20–25% lower in male and female mutants compared to wild-type animals. These reports indicate that oestrogens also play a central role in several metabolic processes in men. The interrelation between testosterone and oestrogen biosynthesis makes it difficult to separate their respective biological effects. Therefore, it is not unlikely that biological effects formerly attributed to testosterone actually represent effects of oestrogens. In light of the observations in oestrogen-resistant or -deficient males, and because of the wealth of evidence for the role of oestrogens in the (patho)physiology of bone and lipid metabolism, cardiovascular disease and the hypothalamo–pituitary–gonadal axis in women, this review will discuss these areas, focusing on the clinical importance of oestrogens in males. Oestradiol is the most potent oestrogen produced in the body. It is synthesized from testosterone or oestrone via the aromatase- or 17β-hydroxysteroid dehydrogenase (17β-HSD) enzymes, respectively (Fig. 1). The total oestradiol production rate in the human male has been estimated to be 35–45 µg (0·130–0·165 µmol) per day, of which approximately 15–20% is directly produced by the testes (Baird et al., 1969a; MacDonald et al., 1979). Roughly 60% of circulating oestradiol is derived from peripheral aromatization of circulating testosterone and 20% is the product of peripheral conversion of oestrone (Baird et al., 1969a). Sources of circulating oestrogens in men. Figures indicate production in µmol/24 h (data derived from Baird et al., 1969a and Saez et al., 1972). *Combined production from adrenal secretion and peripheral conversion of DHEA and DHEAS. Oestrone is the product of peripheral aromatization of androstenedione which is partly produced by the adrenal glands and partly derived from peripheral conversion of testosterone. Oestrone can also be directly secreted by the adrenals (Baird et al., 1969b). The testes contribute more to the total amount of circulating oestradiol than the adrenal glands. Therefore suppression of adrenal steroid synthesis using dexamethasone leads to moderately decreased oestradiol levels (Veldhuis et al., 1992), whereas orchiectomy leads to a more dramatic suppression of plasma oestradiol concentrations (Bartsch et al., 1977; Moorjani et al., 1988). Of the circulating oestradiol only 2–3% is free, most hormone is bound to albumin or sex hormone binding globulin (SHBG) (Dunn et al., 1981). Only the nonSHBG-bound fraction is considered to be bioactive. One of the largest studies on peripheral levels of oestradiol in 1640 men aged 38–70 showed a mean total serum oestradiol concentration of 110 ± 54 pmol/l (mean ± SD; Longcope et al., 1990). These concentrations are comparable to those in women in the early follicular phase of the menstrual cycle. Oestrogen concentrations in postmenopausal women decrease to levels significantly lower than in men of the same age. The plasma concentrations of testosterone and androstenedione tend to decrease with advancing age in men (Vermeulen, 1991; Simon et al., 1992; Field et al., 1994; Ferrini & Barret-Connor, 1998). Oestradiol levels in men decrease mildly after the age of 30 (Simon et al., 1992), remain constant until the age of 75 (Drafta et al., 1982; Zumoff et al., 1982) and decrease significantly after that age (Zumoff et al., 1982; Ferrini & Barret-Connor, 1998). Circadian variation of oestradiol levels has hardly been investigated but is theoretically likely as levels of both testosterone and androstenedione show a circadian rhythm, being highest early in the morning. Jejuna et al. (1991) found a nadir of serum oestradiol concentrations between 24·00 and 02·00 h, and a zenith between 15·00 and 17·00 h in six healthy men (mean age 33 years). Surprisingly, the oestradiol circadian rhythm in this study was in counterphase with the testosterone circadian rhythm. Murono et al. (1982) measured oestradiol concentrations at 08·30 and 17·00 h in eight young men (mean age 34) and 10 elderly men (mean age 73) but found no significant difference between morning and afternoon values. The variation in oestradiol levels through the day in men is slight and in no way comparable to the dramatic changes in plasma levels during the menstrual cycle in women. This means that a single measurement of oestradiol in peripheral blood will give a good indication of the oestrogen exposure in men. Clinical syndromes characterized by altered peripheral concentrations of total oestradiol have been summarized in Table 1. The aromatase enzyme, localized in the endoplasmic reticulum of the oestrogen-producing cell, is encoded by the CYP19 gene. This gene is a member of the CYP gene family, encoding a class of enzymes active in the hydroxylation of endogenous and exogenous substances. The CYP19 gene is localized on chromosome 15 and comprises nine coding exons and several untranslated exons upstream of codon II, named exons I1–I5. The finding of aromatase transcripts with specific 5′-termini in different tissues indicates that there are various tissue-specific promoters each using its own exon I. These promoters are under the influence of different transcription factors such as gonadotrophins (gonadal promotor II) and IL-6, IL-11 and TNF-α (adipose/bone promotor I.4; for review see Simpson & Davis, 2001). As exon I is not translated, these different transcripts are all translated to the same protein. Aromatase activity has not only been demonstrated in testes and ovaries but also in brain (Stoffel-Wagner et al., 1999), fat tissue (Schindler et al., 1972; Longcope et al., 1978), muscle (Longcope et al., 1978), hair (Schweikert et al., 1975), bone (Schweikert et al., 1995; Janssen et al., 1999), vascular tissue (Harada et al., 1999; Murakami et al., 2001) and placenta (Thompson & Siiteri, 1974). To date, three males with aromatase deficiency have been described: two adults (Morishima et al., 1995; Carani et al., 1997) and one newborn (Deladoey et al., 1999). Oestradiol levels in these males were extremely low. Both adult aromatase-deficient men demonstrated a remarkably low bone mass and unfused epiphyses leading to linear growth into adulthood and above average body length. Sexual and pubertal development in these men were normal. One man had increased testicular volume, markedly raised testosterone concentrations and elevated gonadotrophins. The other man had small testicles with a low plasma testosterone concentration. A brother of this man, however, also had small testicles and low plasma testosterone despite a normal aromatase enzyme, suggesting an unrelated second condition. Once treated with oestradiol, epiphyses closed and bone mineral density (BMD) increased (Bilezikian et al., 1998). A boy showing increased extraglandular aromatase activity was described by Hemsell et al. (1977). This prepubertal boy presented with gynaecomastia, accelerated growth and premature bone maturation due to excessive peripheral oestrogen synthesis of unknown origin. The measured conversion rate of androstenedione to oestrone was 50 times higher compared to the conversion rate in normal prepubertal boys. Berkovitz et al. (1985) presented a family in which gynaecomastia occurred in five boys at age 10–11. Fractional conversion rates of androstenedione to oestrone were 10 times the value found in normal prepubertal boys. The underlying genetic defect in these cases was not elucidated. A 17-year-old boy with the same syndrome was more recently described by Bulun et al. (1997). Sequencing of the aromatase gene did not reveal mutations in the promoter or coding regions. Increased androgen aromatization can also be caused by hepatocellular carcinoma (Bulun et al., 1997), adrenocortical tumours (Young et al., 1996) and testicular tumours (Aiginger et al., 1981; Bulun et al., 1997). In these tumours, inappropriate amounts of the aromatase enzyme are expressed. Peripheral androgen aromatization is enhanced in subjects with increased body mass index (BMI; Kley et al., 1980a). Massively obese men show markedly increased plasma oestradiol concentrations and low testosterone concentrations (Kley et al., 1980b; Strain et al., 1982, 1988). After weight reduction these alterations can be reversed (Stanik et al., 1981), underlining the importance of adipose tissue for peripheral aromatization of androgens. Elevated plasma oestradiol levels are also observed in men with cirrhosis of the liver despite decreased plasma testosterone levels (Gordon et al., 1975; Longcope et al., 1984). The metabolic clearance rate of oestrogens in liver cirrhosis patients seems to be unaltered (Longcope et al., 1984). The observed hyperoestrogenism could therefore be caused by an unexplained increment of androgen aromatization. Klinefelter's syndrome also leads to relative hyperoestrogenism with a similar pattern of metabolic alterations as in liver cirrhosis patients (Wang et al., 1975). Hemsell et al. (1974) demonstrated increased efficiency of peripheral conversion of androstenedione to oestrone with increasing age probably as a result of increased aromatase expression in adipose tissue (Bulun & Simpson, 1994). 17β-Hydroxysteroid dehydrogenase (17β-HSD, or 17-ketosteroid reductase) actually represents a group of enzymes of which, to date, 11 subtypes have been described (Adamski & Jakob, 2001). These enzymes are important in hormone metabolism because they catalyse the conversion of biologically inactive 17-keto-steroids (androstenedione and oestrone) into their active 17β-hydroxysteroid counterparts (testosterone and oestradiol) or vice versa. The enzymes are numbered in the order they were cloned. The subtypes are structurally quite different and differ in localization and substrate preference. The type 1 isoform for instance preferentially metabolizes oestrone to oestradiol and is found in the human ovary and placenta. The type 2 isoform preferentially converts oestradiol and testosterone to oestrone and androstenedione, respectively. This subtype is abundantly expressed in all kinds of tissue and it has been suggested that by oxidizing androgens and oestrogens to their less active forms it protects these tissues from steroid actions (Vihko et al., 2001). The type 3 isoform is predominantly expressed in the testes (Geissler et al., 1994). The clinical syndrome of 17β-HSD type 3 deficiency is frequently described and consists of male pseudohermaphroditism due to deficient testicular testosterone biosynthesis. The clinical picture can be indistinguishable from the androgen insensitivity syndrome but patients can be identified by low testosterone/androstenedione ratios in peripheral blood and by mutation analysis (Boehmer et al., 1999). Other 17β-HSD subtypes are expressed in all kinds of tissues including osteoblasts (Janssen et al., 1999; Peltoketo et al., 1999; Feix et al., 2001; Adamski & Jakob, 2001 for review). As described above, both aromatase and the 17β-HSD enzymes are important mediators of androgen and oestrogen metabolism. The presence of these enzymes in the gonads is essential for adequate sex steroid synthesis in men and women. The extragonadal localization of these enzymes, however, also implies a local role in steroid hormone metabolism whereby plasma-derived sex steroids can locally be converted into more or less active hormones, a process earlier named intracrinology (Labrie, 1991). A demonstration of this phenomenon was given by Janssen et al. (1999) in a human osteoblast cell line in which both aromatase and 17β-HSD were present. Administration of testosterone resulted in local production of both androstenedione and oestradiol and, interestingly, both aromatase and 17β-HSD reductive activity declined with differentiation. This shows that local tissue concentrations of androgens and oestrogens are not only dependent on peripheral blood hormone levels but also on local conversion by aromatase and 17β-HSD isoenzymes. In men, but also in postmenopausal women, peripheral conversion of androgens is of vital importance for oestrogen formation. This suggests that in men and postmenopausal women peripheral steroid levels cannot always be relied upon as a measure of local androgenic or oestrogenic activity (Labrie et al., 1997). The oestrogen receptors (ERs) are members of the steroid receptor family. All members of this family share similar characteristics. These include a separate hormone binding domain, a high-affinity DNA binding domain, a tendency to form dimers and an enhanced affinity for the cell nucleus in the presence of bound hormone. To date, two ER subtypes have been cloned, called ERα and ERβ (Kuiper et al., 1996). The two subtypes are highly homologous in DNA and ligand binding domains but overall homology is only 55%. The binding affinity of ERα for oestradiol is somewhat higher compared to that of ERβ (kDa 0·1 nmvs. 0·4 nm). Both subtypes are widely distributed throughout the body. ER mRNA or ER immunoreactivity of both subtypes has been demonstrated in the prostate (Leav et al., 2001), osteoblasts (Braidman et al., 2000, 2001), cartilage (Nilsson et al., 1999; Ushiyama et al., 1999), adipose tissue (Pedersen et al., 2001), brain (Ishunina & Swaab, 2001) including pituitary (Shupnik et al., 1998), and testis (Makinen et al., 2001). Both ER subtypes have been knocked out in male mice. The different phenotypes are summarized in Table 2 and compared with phenotypic characteristics of the aromatase knockout mouse. The observations presented in Table 2 suggest an important most likely indirect role for ERα-bound oestrogen in spermatogenesis. Studies by Hess et al. (1997, 2000) indicated that the efferent ductules of ERβ knockout mice fail to resorb luminal fluids leading to fluid accumulation in the seminiferous tubules, eventually resulting in tubular atrophy and infertility (see also O’Donell et al., 2001 for review). Although Krege et al. (1998) and Weihua et al. (2001) found signs of prostate and bladder epithelial hyperplasia in older ERβ knockout mice this was not confirmed by others (Dupont et al., 2000). The increased levels of LH and testosterone in the ERβ knockout mice are most likely the result of decreased negative feedback of oestradiol on the pituitary gland and/or hypothalamus, thus implying that this effect is at least partly mediated by ERα. The effect of oestradiol on male bone seems to be mediated by ERα, although both ER subtypes are present in human osteoblasts (Arts et al., 1997; Braidman et al., 2000, 2001). ERα knockout mice and aromatase knockout mice show similar alterations in bone length and bone density. Heterozygous ERα knockout mice are phenotypically normal and show unaffected fertility. Crosses of the heterozygous mice resulted in live birth of offspring containing the traditional Mendelian distribution of genotypes. It is not known to what extent the observations in rodents can be translated to humans. To date, only one homozygous ERα-deficient man has been described with phenotypic abnormalities similar to those observed in ERα knockout mice. These remarkable cannot be and ERα mutations in the human male therefore be This indicates that ERα mutations in are in early or The of heterozygous ERα mutations in is ERβ knockout mice are phenotypically hardly and of mutations in this receptor subtype in the human can be more however, to be in on ER and is the of this but can be & 1999; et al., 2001) It is known that testosterone gonadotrophin from the pituitary et al., et al., et al., by effects or by suppression of hormone hormone The aromatization to oestradiol is in this feedback observations indicate that androgens can influence gonadotrophin being a can gonadotrophin secretion at et al., 1975; et al., et al., and males have elevated gonadotrophin levels despite normal plasma oestradiol concentrations & et al., 1979). of an androgen to men leads to increased gonadotrophin secretion et al., et al., 1994; et al., 1994). oestrogens at or also have effects on gonadotrophin in men et al., 1975; et al., et al., et al., This effect has been for the of of or oestrogens gonadotrophin and testosterone levels Administration of or which are oestrogen receptor at the pituitary and/or resulted in of despite of testosterone levels & et al., et al., Oestrogen insensitivity (Smith et al., aromatase deficiency (Morishima et al., 1995; Carani et al., 1997) and of the aromatase et al., et al., all lead to elevated gonadotrophin levels despite normal or elevated serum testosterone a with the aromatase in both normal men and men from indicated that oestrogens have an effect on both and pituitary et al., 2000). These observations indicate that oestrogens and androgens have effects on gonadotrophin in men. their relative under remain to be In this it is important to that oestradiol its influence at levels, the average serum testosterone concentration is in the This influence of oestradiol and testosterone on gonadotrophin secretion is important oestradiol levels indicate a or pituitary oestradiol levels a suppression of a for the of this As is described oestrogens in men have with oestrogen is therefore not with bone the for androgen for this of this is a man, for had extremely peripheral oestradiol levels as a result of adrenals for et al., 1996). This bone mineral density was normal. In the observations described above in ERα knockout mice et al., aromatase knockout mice et al., and men with ERα (Smith et al., 1994) or aromatase et al., 1997) mutations suggest an effect of oestrogens on and but their remain to be Aromatase (Stoffel-Wagner et al., and ERα and (Ishunina et al., 2001) are present in human The importance of oestrogens in male however, is Increased expression of ERα and in the nucleus of of male and female patients with disease suggests a role for oestrogens in the of this In women there is evidence that endogenous oestrogens et al., et al., 2001). In a however, elderly men with higher endogenous oestradiol levels on et al., 1999). The aromatase-deficient (Morishima et al., 1995; Carani et al., 1997) and oestrogen-resistant men (Smith et al., 1994) showed and no abnormalities. studies in show that is less in female compared to male or and that oestrogen to male can decrease The value of oestrogen in postmenopausal women to from disease however, & for review). It therefore that the importance of oestrogens in both male and female from the is at this steroids are essential to bone in in men is with of bone mass et al., 1997). men not only from androgen deficiency but also most of the substrate for oestrogen biosynthesis it is not to of androgens or oestrogens is the of the observed negative effects on show no growth pattern during but bone mass is lower relative to female and lower compared to normal men et al., 1995; et al., et al., 2000). This difference can partly be by relative as a result of with oestrogen in patients with the androgen insensitivity with hormone and, to a bone mineral density is lower in males compared to normal and males. to female treated with oestrogens and not bone despite markedly testosterone levels et al., et al., 1998). In most studies the plasma total testosterone after for age and is not to at different of the et al., et al., et al., 1997; et al., 1997; et al., 2000). In studies androgen or testosterone is to total body et al., et al., 2001), at et al., 1997), et al., et al., 1997) or et al., et al., 1997; et al., 2000). In a study in older men, serum testosterone levels were not with et al., 2000). These observations suggest that androgens have a role in bone development and in men. In oestrogen insensitivity (Smith et al., 1994) and aromatase deficiency (Morishima et al., 1995; Carani et al., 1997) decreased in men, despite normal or elevated testosterone In studies plasma concentrations of total oestradiol et al., 1997; et al., et al., et al., 2001) and oestrogen et al., 1997; et al., et al., et al., 2001) were to in men. oestradiol levels are with of bone in men et al., 2001). et al. (2001) showed that bone in men is to total and levels of but not of testosterone. indicate that male is with low peripheral oestradiol levels et al., 2000) and ERα expression in bone (Braidman et al., 2000). men with low serum oestradiol levels are at higher of compared to men with oestradiol levels et al., 2000). et al. described a study in which an was to the effects of oestradiol and testosterone on male elderly men by a and an aromatase by with oestradiol or a of the two was not to bone as measured by the of and in Oestradiol decreased and significantly compared to but only and Oestradiol was more in increasing bone and the of type compared to testosterone. (Morishima et al., 1995; Carani et al., 1997) or males (Smith et al., 1994) show growth during is no growth and epiphyses not This in a than average body length. the other increased aromatase activity not only but also leads to accelerated growth and premature of epiphyses et al., Administration of an aromatase to boys with male due to an LH receptor mutation leads to of growth pattern despite testosterone levels in the adult et al., This the importance of oestradiol in growth and not only in but also in boys. oestradiol levels in prepubertal are eight times higher compared to those in prepubertal probably the more maturation in 1997). these observations suggest that oestrogens are of importance for bone development and in men. the of cardiovascular disease significantly between men and women the between levels of sex steroids and lipid metabolism has been investigated in In most studies in men, plasma levels of total or testosterone are to density et al., et al., & 1991; et al., but to plasma levels et al., et al., Oestradiol is to but this is for plasma testosterone concentration et al., between oestradiol and low density are studies found a negative et al., et al., but others found the & 1991). on the effect of concentrations of oestrogens on lipid profile in men are derived from studies on the of carcinoma patients with The observed effects are of the dramatic decrease in testosterone concentration because the differ compared to lipid levels in men after with and/or oestrogens leads to an of and and total levels tend to decrease & 1981; et al., 1982; Moorjani et al., et al., et al. demonstrated increased synthesis but also a more resulting in decreased concentrations after oestradiol secretion rates and higher of were also observed in men et al., the lipid profile by of oestrogens to men, this was because of increased cardiovascular and et al., et al., et al., 1998). a study the effects of oestrogen to men after was because of of were of a higher of in the group of oestrogens to men, however, showed, besides a of lipid a small but significant reduction in blood and a reduction of and et al., 2001). effects of oestrogens in men were described Oestradiol was to of human in et al., oestrogens can the and of in men et al., 1997; et al., 1998). These however, were not observed after of oestradiol et al., of their these effects of oestrogens are not to be mediated by the oestradiol, bound to a can directly leading to of endothelial et al., 2000). As both ER and aromatase are present in male vascular tissue et al., et al., 1999; Murakami et al., 2001), these actions of oestrogens be of in male vascular these studies in men not show a between the plasma concentration of endogenous oestradiol and the extent of confirmed disease et al., et al., et al., peripheral disease et al., 1997), et al., or et al., In to plasma oestradiol levels to the of in men et al., & et al., et al., In the oestrogen-resistant male (Smith et al., low total and levels were and significant in the was demonstrated by (Sudhir et al., The adult aromatase-deficient males showed total and but low (Morishima et al., 1995; Carani et al., 1997). These levels after oestrogen et al., 1997). It is difficult to the difference between the lipid in these two syndromes in the oestrogen-resistant oestradiol levels influence lipid levels via ERβ or a The of the importance of oestrogens in men has of The role of oestrogens in the of carcinoma (Leav et al., 2001; et al., 2001; et al., 2001) is Other on oestrogens and male et al., 2001; et al., 2001), et al., 1999), et al., 1999; et al., 2000) or cardiovascular disease (Sudhir & 1999; et al., et al., 2001; et al., The of androgens and the of two oestrogen receptors and the of effects of oestrogens the tissue-specific of aromatase activity by the five promoters of the aromatase enzyme, the specific and distribution of the 17β-hydroxysteroid dehydrogenase and the demonstration of ER mutations and indicate that serum concentrations of oestrogens cannot always be relied upon as of oestrogen concentrations and hormone Other are raised by oestrogen receptor These have tissue-specific or actions on the & et al., for and are to women because of their and postmenopausal bone The of the effect of oestrogens in males not with in men at present but were et al., et al., et al., et al., 2000) and will be to more in the effects of these substances. play a role in metabolic processes in men. only are oestrogens important for growth and they also to and bone Oestradiol has an effect on gonadotrophin a effect on lipid metabolism and a effect on human male fertility. has to be to the clinical of this in encoding the aromatase and 17β-HSD enzymes or the oestrogen receptors lead to alterations in bone metabolism, lipid metabolism, the axis and in men. The increased of the of oestrogens in men will probably lead to the of more in oestradiol metabolism. the of present of the effects of oestrogens to oestrogen to the of premature osteoporosis, and in men.
Language: English
Subfield: Endocrinology
Open Access status: bronze
OpenAlex ID: W2091466024
FWCI: 1.022
Cites: 181
Cited by: 92
Related to: 10